New analysis finds marked acceleration in longev
Author: Michael
New funding signals growing seriousness in pet l
Allegro NV, a biomedical company developing nanot
Telomir Pharmaceuticals has announced new preclin
Form Bio and Cure Rare Disease have entered a str
NeuroSense Therapeutics Ltd.
Serina Therapeutics, a clinical-stage biotechnolo
BlueRock Therapeutics says that its Phase I trial
Fractyl Health has revealed preclinical results f
Manjit Sareen reflects on the first Asia-Pacific